×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
07:13 am
nrix
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom's Macroglobulinemia [Yahoo! Finance]
Low
Report
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom's Macroglobulinemia [Yahoo! Finance]
12/19
07:00 am
nrix
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
Low
Report
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
12/11
08:21 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its price target raised by analysts at HC Wainwright from $30.00 to $35.00. They now have a "buy" rating on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its price target raised by analysts at HC Wainwright from $30.00 to $35.00. They now have a "buy" rating on the stock.
12/10
08:58 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $35.00 price target on the stock.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $35.00 price target on the stock.
12/10
08:01 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
12/9
06:13 pm
nrix
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting [Yahoo! Finance]
Medium
Report
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting [Yahoo! Finance]
12/9
06:00 pm
nrix
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
Medium
Report
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
12/6
08:06 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $35.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $35.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
10/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
IN-LINE
Report
6.5%
nurix therapeutics, inc. - common stock
7/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
8.1%
nurix therapeutics, inc. - common stock
4/10/2024
07:00 am
nrix
nurix therapeutics, inc. - common stock
BEAT
Report
-12.5%
nurix therapeutics, inc. - common stock
2/15/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
0.2%
nurix therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/2
05:29 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Jan 02 Filed by: Ring Christine
Neutral
Report
Form 4 Nurix Therapeutics, Inc. For: Jan 02 Filed by: Ring Christine
1/2
04:20 pm
nrix
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Neutral
Report
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
12/10
06:55 am
nrix
Form 8-K Nurix Therapeutics, Inc. For: Dec 09
Low
Report
Form 8-K Nurix Therapeutics, Inc. For: Dec 09
12/6
11:35 am
nrix
Form SCHEDULE 13G Nurix Therapeutics, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G Nurix Therapeutics, Inc. Filed by: FMR LLC
12/2
06:00 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Dec 02 Filed by: Ring Christine
Low
Report
Form 4 Nurix Therapeutics, Inc. For: Dec 02 Filed by: Ring Christine
12/2
04:36 pm
nrix
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
High
Report
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
11/14
09:01 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC
High
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC
11/14
04:22 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: BAKER BROS. ADVISORS LP
High
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: BAKER BROS. ADVISORS LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: